QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, today announced the implementation of a leadership development plan. The plan combines succession planning with senior management team expansion in order to fully capitalize on the Company’s numerous growth opportunities and maximize the potential for shareholder returns. In addition, the plan is designed to develop an orderly leadership succession program while maintaining the company’s strong momentum.
